{"version":"1.0","provider_name":"Frezza Partners","provider_url":"https:\/\/frezzapartners.com\/en\/","author_name":"Frezza Partners","author_url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/","title":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7xaucEzeVt\"><a href=\"https:\/\/frezzapartners.com\/en\/dompe-x-therapeutics-in-usa\/\">Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/frezzapartners.com\/en\/dompe-x-therapeutics-in-usa\/embed\/#?secret=7xaucEzeVt\" width=\"600\" height=\"338\" title=\"&#8220;Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA&#8221; &#8212; Frezza Partners\" data-secret=\"7xaucEzeVt\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/frezzapartners.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","thumbnail_width":1500,"thumbnail_height":846,"description":"photo by dompe.com &nbsp; Mauro Ferrari \u00e8 il nuovo Presidente &amp; CEO della neonata Domp\u00e9 X-Therapeutics (DXT), dedicata allo sviluppo della nuova generazione di terapie che unsicono AI, matematica multiscala, nanotecnologie e farmaceutica. Lo scopo aziendale \u00e8 quello di creare nuove metodologie per personalizzare alcuni tipi di malattie. La sede della nuova azienda sar\u00e0 San Francisco, dove Domp\u00e9 \u00e8 gia presente dal 2018. Il gruppo ha gi\u00e0 uan rete di open innovation che coinvolge diversi centri importanti in tutto il..."}